September 24, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

First quarter expenses more than doubled at Sienna Biopharmaceuticals

IN THIS ARTICLE

Operating expenses for Westlake Village-based Sienna Biopharmaceuticals more than doubled for the first quarter to $18.5 million as it launched a third product into clinical trials. The pre-revenue company said net loss came to $17.1 million, or 85 cents per share, and it burned through $14.5 million for the quarter ended March 31, leaving it…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.